Discover
RCEL
AVITA Medical, Inc.
4.67
2 x 3.48
2 x 5.31
bid
ask
+
0.54
13.08%
2 @ 04:00 PM
4.60 -0.07 (1.50%)
| Ytd | 35.36% | |
| 1y | -11.39% |
4.15
day range
4.85
3.22
52 week range
7.12
| Open | 4.16 | Prev Close | 4.13 | Low | 4.15 | High | 4.85 | Mkt Cap | 143.73M |
| Vol | 611.91K | Avg Vol | 282.05K | EPS | -1.56 | P/E | N/A | Forward P/E | -14.33 |
| Beta | 1.54 | Short Ratio | 10.24 | Inst. Own | 23.45% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 4.25 | 200-d Avg | 4.26 | 1yr Est | 16.81 |
| Income Statement | |||
| Total Revenue | 19.25M | ||
| Revenues (USD) | 19.25M | ||
| Cost of Revenue | 3.52M | ||
| Gross Profit | 15.73M | ||
| Operating Expenses | 24.53M | ||
| Research and Development Expense | 5.63M | ||
| Selling, General and Administrative Expense | 18.90M | ||
| Operating Income | -8.80M | ||
| Interest Expense | 1.42M | ||
| Income Tax Expense | -11.00K | ||
| Net Income | -10.61M | ||
| Net Income Common Stock | -10.61M | ||
| Net Income Common Stock (USD) | -10.61M | ||
| Consolidated Income | -10.61M | ||
| Earnings per Basic Share | -0.35 | ||
| Earnings per Basic Share (USD) | -0.35 | ||
| Earnings per Diluted Share | -0.35 | ||
| Earning Before Interest & Taxes (EBIT) | -9.20M | ||
| Earning Before Interest & Taxes (USD) | -9.20M | ||
| Weighted Average Shares | 30.54M | ||
| Weighted Average Shares Diluted | 30.54M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.31M | ||
| Cash and Equivalents (USD) | 8.31M | ||
| Investments | 5.95M | ||
| Investments Current | 5.95M | ||
| Trade and Non-Trade Receivables | 9.89M | ||
| Current Assets | 31.65M | ||
| Property, Plant & Equipment Net | 10.88M | ||
| Total Assets | 51.54M | ||
| Debt Current | 46.14M | ||
| Total Debt | 48.12M | ||
| Current Liabilities | 66.67M | ||
| Debt Non-Current | 1.98M | ||
| Total Liabilities | 74.71M | ||
| Accumulated Retained Earnings (Deficit) | -419.01M | ||
| Accumulated Other Comprehensive Income | 648.00K | ||
| Shareholders Equity | -23.17M | ||
| Shareholders Equity (USD) | -23.17M | ||
| Assets Non-Current | 19.90M | ||
| Total Debt (USD) | 48.12M | ||
| Deferred Revenue | 281.00K | ||
| Goodwill and Intangible Assets | 5.44M | ||
| Inventory | 6.12M | ||
| Liabilities Non-Current | 8.04M | ||
| Trade and Non-Trade Payables | 7.22M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 860.00K | ||
| Net Cash Flow from Financing | 6.10M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.93M | ||
| Capital Expenditure | -19.00K | ||
| Issuance (Repayment) of Debt Securities | 6.10M | ||
| Net Cash Flow from Investing | 2.04M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.06M | ||
| Net Cash Flow from Operations | -10.07M | ||
| Share Based Compensation | 1.10M | ||